BURLINGTON, Ontario, Nov. 19, 2021 - (BUSINESS WIRE) - Element Nutritional Sciences Inc. (CSE: ELMT; FRANKFURT: 93X) (the "Company" or "Element") is pleased to...
Recorlev (levoketoconazole), Strongbridge Biopharma's oral investigational therapy for endogenous Cushing's syndrome, resulted in sustained improvements in cortisol and glycemic control in patients with Cushing...